...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Another Canadian Biotech get bought , not Zenith yet

great to see this happening but it's almost like another dagger in the heart each time we see a deal, just another one of thousands of paper cuts. Koolaid should be spilling again soon saying "deal by end of June" for the forth or fifth year in a row!

Share
New Message
Please login to post a reply